Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shinjiro Tamai"'
Autor:
Daisuke Mori, Masato Hayashi, Ryoko Honda, Haruna Tanoue, Midori Kobayashi, Motoko Shimada, Shinjiro Tamai, Hiroki Nomi, Katsuyuki Nagatoya, Atsushi Yamauchi
Publikováno v:
Renal Replacement Therapy, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Background We aimed to examine the impact of anemia on the risk of further deterioration in renal function among elderly and nonelderly patients with chronic kidney disease (CKD). Methods In this retrospective cohort study, we included 1098
Externí odkaz:
https://doaj.org/article/9de3b2f096824901a6b1aff54aca8e0b
Autor:
Yukimasa Iwata, Shoki Notsu, Yushi Kawamura, Waka Mitani, Shinjiro Tamai, Madoka Morimoto, Masafumi Yamato
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Sodium–glucose cotransporter 2 inhibitors (SGLT2i) exhibit renoprotective effect in patients with chronic kidney disease (CKD) and reduce serum uric acid (UA) in patients with diabetes mellitus. However, it is not clarified whether SGLT2i
Externí odkaz:
https://doaj.org/article/a67b8886f4824e2896dedc577ebab124
Autor:
Daisuke Mori, Yuta Namiki, Ayaka Sugimachi, Manabu Kado, Shinjiro Tamai, Hiroki Nomi, Ryota Haga, Katsuyuki Nagatoya, Atsushi Yamauchi
Publikováno v:
Journal of Renal Nutrition. 33:420-427
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a8d35a9819ec43437b824442157436d
https://doi.org/10.1053/j.jrn.2022.12.009
https://doi.org/10.1053/j.jrn.2022.12.009
Autor:
Hiroki Nomi, Daisuke Mori, Naoyuki Shimada, Ryota Haga, Katsuyuki Nagatoya, Atsushi Yamauchi, Hideaki Kawai, Maho Tokuchi, Shinjiro Tamai, Natsumi Inoue
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Plasma potassium levels are impacted by decreased kidney function and are known to be associated with increased mortality, adverse cardiovascular events and adverse kidney events. However, the prognostic implication of urinary pot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a72c0cb3ac03df261291db1dadc819b0
https://doi.org/10.1093/ndt/gfab090.0027
https://doi.org/10.1093/ndt/gfab090.0027
Autor:
Naoyuki Shimada, Daisuke Mori, Hideaki Kawai, Maho Tokuchi, Katsuyuki Nagatoya, Shinjiro Tamai, Hiroki Nomi, Natsumi Inoue, Atsushi Yamauchi, Ryota Haga
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Tolvaptan (TV) slows down the increase in total kidney volume (TKV) in patients with autosomal dominant polycystic kidney disease (ADPKD). The efficacy of TV in patients with moderate-to-severe renal dysfunction (RD) in ADPKD rema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af77d321eea5562591edb03a5d3e2ccb
https://doi.org/10.1093/ndt/gfab080.0023
https://doi.org/10.1093/ndt/gfab080.0023